Midostaurin the First Targeted Therapy to Improve Survival in AML: Potentially Practice-Changing
Am Health Drug Benefits
.
2016 Feb;9(Spec Issue):1-21.
Author
Phoebe Starr
PMID:
27014400
PMCID:
PMC4782225
No abstract available